Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Amplicore, Inc. Announces Closing of a Successful $4M Seed Funding Round 2021-03-26 05:19
Antengene Appoints Kevin Lynch as Chief Medical Officer 2021-03-25 23:26
Antengene Appoints Bo Shan as Chief Scientific Officer 2021-03-25 22:36
CStone Pharmaceuticals Reports Financial Results and Business Highlights for Full-year 2020 2021-03-25 22:03
SOPHiA GENETICS and Hitachi Announce Collaboration to Advance Data Driven Precision Medicine 2021-03-25 21:00
Össur Recognized by World Intellectual Property Organization (WIPO) as Leading Assistive Technology Development 2021-03-25 20:55
China Eastern Flies Vaccines to Dominican Republic 2021-03-25 19:22
BioNTech Chairman Helmut Jeggle joins the Board of IQM Quantum Computers 2021-03-25 18:29
111 Signs Strategic Cooperation Agreement with Jianming Pharmaceutical to Develop Chronic Disease Management Platform 2021-03-25 17:00
AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine 2021-03-25 17:00
GenScript Signs a Strategic Partnership with the Theragen Etex and MedPACTO for Therapeutic Antibody Drug development 2021-03-25 16:35
Positive Phase III Clinical Results for EirGenix's Proposed Trastuzumab Biosimilar 2021-03-24 23:27
Ascentage Pharma's First Third-Generation BCR-ABL Inhibitor in China Olverembatinib (HQP1351) Recommended for Breakthrough Therapy Designation 2021-03-24 19:07
LimaCorporate And HSS Partner To Open First Provider-based Design And 3D Printing Center For Complex Joint Reconstruction Surgery 2021-03-24 16:00
Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate 2021-03-24 14:18
Forest Hills Lab is filing an IND to initiate a clinical phase 2 study on Parkinson's disease with the US FDA 2021-03-24 12:25
Mindray Releases New Ceiling Supply Unit, Creating a More Optimized ICU Environment 2021-03-24 11:49
CStone Announces New Drug Approval of GAVRETO(R) (pralsetinib) as First Selective RET Inhibitor in China, Providing a New Therapy for a Subset of Non-Small Cell Lung Cancer Patients 2021-03-24 10:46
Transcenta Announces Appointments of Dr. Xichen Zhang as Senior Vice President of Manufacturing and Dr. Steven Yu as Senior Vice President of DMPK and Translational Science 2021-03-24 08:00
Adults with obesity treated with semaglutide 2.4 mg achieved and maintained a significant amount of weight loss in a 68-week trial 2021-03-24 04:41
1 411 412 413 414 415 896